Millipore Acquires NovAseptic AB: Broadens Offering to Biotech and Pharmaceutical Industry


Millipore Corporation announced that it has completed the acquisition of over 90% of the shares of NovAseptic AB from the company's majority shareholders. Millipore is in the process of acquiring the remaining shares from the minority shareholders.

Martin Madaus, Millipore's Chairman, CEO and President, noted: "NovAseptic brings innovative and differentiated products that our biotech and pharmaceutical customers value highly for manufacturing biologics and for monitoring bio-manufacturing processes. There is a great fit strategically and tactically, and we've added exceptional technology and talent to Millipore."

NovAseptic, based in Gothenburg, Sweden, provides a range of innovative solutions for aseptic processing applications in biotech and pharmaceutical manufacturing operations. NovAseptic's products include a unique disposable sampling system (NovaSeptum(R)) and a range of high-performance mixers, valves, and connectors.

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy